Novartis Upgrades FullYear Guidance on Sales and Profit Outlook LSTA Q3 2025 Earnings NarrowerThanExpected Loss Marks Progress in ClinicalStage Biotech Traders Speculate on Next US Government Stake IonQ Micron Anduril Among Top Candidates